Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +40.55%
#3 CoW Protocol CoW Protocol +38.40%
#4 Enso Enso +22.30%
#5 Codatta Codatta +21.08%
#6 Tutorial Tutorial +20.73%
#7 Walrus Walrus +19.75%
#8 BOOK OF MEME BOOK OF MEME +17.49%
#9 Humanity Humanity +13.91%
#10 Ribbita by Virtuals Ribbita by Virtuals +13.35%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Therma Bright Inc. Therma Bright Inc.

Therma Bright Inc.

THRM
Rank in Stocks #36876
Established in Toronto, Canada, in 2001 as The Jenex Corporation before... Established in Toronto, Canada, in 2001 as The Jenex Corporation before rebranding to Therma Bright Inc. in February 2018, Therma Bright Inc. specializes in creating and distributing various medical and consumer health products. Their diverse offerings include rapid COVID-19 diagnostic tests like AcuVid, which screens for both antigens and antibodies. For pain relief, they provide devices such as Benepod, a hot and cold contrast therapy system designed to manage discomfort without medication. The company also addresses circulatory issues with Venowave, a medical compression pump aimed at mitigating symptoms associated with poor circulation. Furthermore, Therma Bright caters to the cosmeceutical industry with products like InterceptCS, a cold sore prevention system utilizing safe, controlled topical heat, and TherOZap, a thermal device that alleviates the pain, itching, and inflammation from insect bites and stings by reducing the inflammatory response. Their clientele spans both individual consumers and healthcare practitioners.
Share Price
$0.03669684
Last synced: 2026-08-13
Market Cap
$2.25M
Change (1 day)
0.00%
Change (1 year)
-27.55%
Country
CA
Trade Therma Bright Inc. (THRM)

Category

Healthcare
P/E ratio for Therma Bright Inc. (THRM)
P/E ratio as of 2026 TTM: 0
According to Therma Bright Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Therma Bright Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.